FFO
ANAB icon

Fortitude Family Office’s AnaptysBio ANAB Stock Holding History

Fortitude Family Office’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8
Closed -$444 – 2276
2026
Q1 		$444 Buy
+8
New +$430 ﹤0.01% 1769
2024
Q4 		– Sell
-31
Closed -$1.04K – 1293
2024
Q3 		$1.04K Hold
31
– – ﹤0.01% 1099
2024
Q2 		$777 Buy
+31
New +$722 ﹤0.01% 898

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Fortitude Family Office's ANAB Position: Q2 2026 in Review

Fortitude Family Office sold out of AnaptysBio (ANAB) in Q2 2026, closing a stake of 8 shares — an estimated $444 sold.

Fortitude Family Office first reported a position in ANAB in Q2 2024 and held it in 3 quarters. The position peaked at $1.04K in Q3 2024. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Fortitude Family Office reported no remaining AnaptysBio position as of Q2 2026 after selling out during the quarter.
  • Fortitude Family Office sold 8 AnaptysBio shares in Q2 2026, an estimated $444.
  • Fortitude Family Office first reported a position in AnaptysBio in Q2 2024 and held it in 3 quarters.
  • Fortitude Family Office's AnaptysBio position peaked at $1.04K in Q3 2024.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.